TransMedics Group, Inc. Financial Ratios — TMDX Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-36.27	-51.49	-28.39	-15.42	19.39	54.24
Return on Assets (%)	- -	- -	-60.02	-45.5	-22.34	-30.82	-17.59	-5.09	4.7	20.33
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	7.11	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	5.31	- -
Gross Margin (%)	12.34	27.81	44.05	58.73	64.88	69.92	69.84	63.77	59.36	59.92
EBITDA Margin (%)	-363.34	-257.59	-149.56	-120.24	-96.75	-124.28	-29.92	-8.5	12.97	22.42
Operating Margin (%)	-370.2	-265.79	-155.47	-125.42	-102.91	-130.29	-33.64	-11.89	8.49	17.93
Incremental Operating Margin (%)	- -	173.44	3.54	- -	158.18	- -	12.64	1.83	33.13	43.36
Pretax Margin (%)	-387.58	-270.54	-182.18	-141.95	-112	-145.99	-38.7	-11.04	8.1	17.76
Profit Margin (%)	-387.58	-270.96	-182.5	-142.12	-112.13	-146.11	-38.77	-10.36	8.03	31.43
Net Income to Common Margin (%)	-387.58	-270.96	-182.5	-142.12	-112.13	-146.11	-38.77	-10.36	8.03	31.43
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.88	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-36.27	-51.49	-28.39	-15.42	19.39	54.24

Credit (USD)

Credit Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	9	34	34	35	44	68	516	518	519
ST Debt	- -	2	- -	- -	- -	- -	1	2	3	13
LT Debt	- -	7	34	34	35	44	66	514	516	506
Total Debt/EBITDA	- -	-0.44	-1.73	-1.2	-1.4	-1.16	-2.42	-25.11	9.05	3.82
Net Debt/EBITDA	- -	0.17	-0.69	-0.5	-0.41	-0.26	5.1	-5.42	3.02	0.18
Total Debt/EBIT	- -	-0.42	-1.66	-1.15	-1.31	-1.11	-2.15	-17.96	13.82	4.78
Net Debt/EBIT	- -	0.16	-0.66	-0.47	-0.38	-0.24	4.53	-3.88	4.6	0.22
EBITDA to Interest Expense	-23.04	-18.47	-7.16	-6.52	-6.23	-9.71	-7.5	-1.9	3.97	9.85
EBITDA-CapEx/Interest Expense	-24.55	-18.71	-7.31	-6.56	-6.34	-10.62	-10.7	-18.5	-5.03	5.55
EBIT to Interest Expense	-23.48	-19.05	-7.44	-6.8	-6.62	-10.18	-8.44	-2.66	2.6	7.88
Interest Expense	1	1	3	4	4	4	4	11	14	14
Common Equity/Total Assets	- -	-456	-456.01	51.9	68.34	50.3	67.61	19.43	28.43	44.28
Long-Term Debt/Equity (%)	- -	- -	- -	62.48	33.36	64.55	35.28	374.57	225.53	106.95
Long-Term Debt/Capital (%)	- -	-4.28	-21.23	38.45	25.01	39.23	25.93	78.68	69.03	50.99
Long-Term Debt/Total Assets (%)	- -	18.5	79.87	32.43	22.8	32.47	23.85	72.79	64.12	47.36
Total Debt/Equity (%)	- -	-5.13	-17.51	62.48	33.36	64.55	36.05	376.05	226.72	109.76
Total Debt/Capital (%)	- -	-5.41	-21.23	38.45	25.01	39.23	26.5	78.99	69.39	52.33
Total Debt/Total Assets (%)	- -	23.38	79.87	32.43	22.8	32.47	24.38	73.08	64.46	48.6
Net Debt to Equity	- -	1.95	-6.99	25.72	9.7	14.17	-76.04	81.19	75.53	5.08
Net Debt/Capital (%)	- -	1.91	-7.51	20.46	8.84	11.17	-265.1	43.12	42.09	4.77
EBITDA	-23	-20	-19	-28	-25	-38	-28	-21	57	136
EBITDA-CapEx	-24	-20	-20	-29	-25	-41	-40	-200	-72	77
Operating Income (Loss)	-23	-20	-20	-30	-26	-39	-31	-29	37	109

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	2.26	1.61	5.01	10.58	3.98	8.5	7.19	5.62	5.47
Current Ratio	- -	3.12	2.77	6.21	12.36	5.11	10.66	9.3	8.3	7.14
Quick Ratio	- -	2.35	1.89	5.41	11.15	4.23	9.67	8.34	7.25	6.41
CFO/Avg Current Liab	- -	- -	-2.22	-2.25	-2.16	-1.64	-1.95	-0.33	0.85	2.58
Common Equity/Total Assets	- -	-456	-456.01	51.9	68.34	50.3	67.61	19.43	28.43	44.28
Long-Term Debt/Equity (%)	- -	- -	- -	62.48	33.36	64.55	35.28	374.57	225.53	106.95
Long-Term Debt/Capital (%)	- -	-4.28	-21.23	38.45	25.01	39.23	25.93	78.68	69.03	50.99
Long-Term Debt/Total Assets (%)	- -	18.5	79.87	32.43	22.8	32.47	23.85	72.79	64.12	47.36
Total Debt/Equity (%)	- -	-5.13	-17.51	62.48	33.36	64.55	36.05	376.05	226.72	109.76
Total Debt/Capital (%)	- -	-5.41	-21.23	38.45	25.01	39.23	26.5	78.99	69.39	52.33
Total Debt/Total Assets (%)	- -	23.38	79.87	32.43	22.8	32.47	24.38	73.08	64.46	48.6
CFO/Total Liabilities	- -	-11.23	-11.09	-63.74	-62.88	-43.06	-51.04	-2.29	8.48	32.4
CFO/CapEx	-16.31	-87.83	-62.16	-195.67	-66.52	-8.2	-3.85	-0.07	0.38	3.25
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.61

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	5.97	4.72	3.82	4.73	5.57	5.3	5.47	6.65
Days Sales Outstanding	- -	- -	61.17	77.29	95.55	77.18	65.5	68.87	66.67	54.86
Inventory Turnover	- -	- -	0.84	0.95	0.78	0.68	1.59	2.7	3.95	5.09
Days Inventory Outstanding	- -	- -	432.21	383.94	469.22	537.16	229.62	135.19	92.33	71.77
Accounts Payable Turnover	- -	- -	2.09	1.95	2.3	3.06	6.79	13.84	15.8	23.74
Accounts Payable Turnover Days	- -	- -	174.98	186.98	158.68	119.21	53.74	26.36	23.1	15.38
Cash Conversion Cycle	- -	- -	318.4	274.25	406.09	495.12	241.38	177.7	135.9	111.25
Inventory to Cash Days	- -	- -	-371.04	-306.65	-373.68	-459.97	-164.11	-66.32	-25.66	-16.91
Inventories	- -	8	9	11	12	15	21	44	47	49
Raw Materials	- -	3	4	5	7	7	11	26	28	26
Work In Process	- -	1	1	1	1	2	2	4	3	2
Finished Goods	- -	4	5	5	4	6	8	15	15	21
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	4,404
- Cash & Cash Equivalents	- -	12	20	20	25	26	201	395	337	488
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	9	34	34	35	44	68	516	518	519
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	4,435
Total Capital	- -	-160	-159	89	139	112	255	653	747	992
Total Debt/Capital (%)	- -	-5.41	-21.23	38.45	25.01	39.23	26.5	78.99	69.39	52.33
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.12
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.32
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.66
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	40.84
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,210
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,241
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	129.42
TTM Sales	6	8	13	24	26	30	93	242	442	605
TTM EBITDA	-23	-20	-19	-28	-25	-38	-28	-21	57	136
TTM Operating Income	-23	-20	-20	-30	-26	-39	-31	-29	37	109
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	63	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	-67	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	39
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	40.84
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	4,435
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	103.29
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.32
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.66
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.96
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.09
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	26
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.45
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.31
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.96
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.54
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.48
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.58
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.22
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.85
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.7
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.21
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.94
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.17
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.8
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.65
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	21.8
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.66
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.21
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	37.53
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	44.17
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.35
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.05
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.29
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.9
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	31.44
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	36.97
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	26.3
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	39.31
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.22
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	32.88
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	128.51
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	145.56
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	4,268
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	5,019
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	3,570

Shares Outstanding	20	19	19	21	27	28	32	33	34	34
Diluted Weighted Avg Shares	14	14	19	14	25	28	30	33	35	41
Basic Weighted Avg Shares	14	14	19	14	25	28	30	33	33	34
Revenue per Share	0.43	0.53	0.68	1.66	1.04	1.1	3.16	7.43	13.29	17.81
EBITDA per Share	-1.56	-1.37	-1.01	-2	-1	-1.36	-0.95	-0.63	1.72	3.99
Operating Income per Share	-1.59	-1.41	-1.05	-2.08	-1.07	-1.43	-1.06	-0.88	1.13	3.19
Basic EPS, GAAP	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.07	5.6
Basic EPS from Cont Ops	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.07	5.6
Diluted EPS, GAAP	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.01	4.69
Diluted EPS from Cont Ops	-1.66	-1.44	-1.23	-2.36	-1.16	-1.6	-1.23	-0.77	1.01	4.69
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.67	-1.6	-1.35	-2.27	-1.23	-1.05	-1.55	-0.4	1.47	5.67
Free Cash Flow per Basic Share	-1.77	-1.61	-1.37	-2.28	-1.24	-1.17	-1.95	-5.91	-2.44	3.93
Cash & Equivalents per Share	- -	1.28	1.05	3.81	4.62	3.33	6.26	12.08	10.01	14.25
Book Value per Share	- -	-8.77	-9.99	2.58	3.82	2.44	5.83	4.2	6.8	13.81
Tangible Book Value per Share	- -	-8.77	-9.99	2.58	3.82	2.44	5.83	3.76	6.39	13.41

TransMedics Group, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)